To learn more about this report, request a free sample copy
The report is titled as ‘Active Pharmaceutical Ingredients Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the active pharmaceutical ingredients market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The active pharmaceutical ingredients market is expected to grow at a significant rate in the near future.
The global active pharmaceutical ingredients market is estimated to reach at a value of US$ 184.7 Bn by the end of 2020 and expected to reach at a value of US$ 309.8 Bn by 2028 with a significant CAGR of 6.7%.
The active pharmaceutical ingredients can be referred to as any biologically or chemically active component or combination of components utilized in a complete pharmaceutical product, which aims to fix up pharmacological action or contrarily to have immediate effect in the diagnosis, healing, alleviation, medical care or prevention of illness, or to have immediate effect in rectifying, restoring, or modifying physiological functions in human beings.
For most of the time, the active pharmaceutical ingredients (APIs) are produced by the pharmaceutical companies only in their respective countries. Although in recent years, the majority of pharmaceutical corporations have preferred to export manufacturing in foreign countries in order to cut off expenses. This has paved the way to essential modifications in the way these drugs are regulated, with more strict guidelines and checks in location.
The constantly increasing number of research and development activities associated with drugs and medicines across the world is majorly boosting the growth of the global active pharmaceutical ingredients market.
In the last few decades, the number of healthcare activities as well as usage of drugs, medicines and biologics in treating patients, worldwide, has also increased tremendously, which further projected to propel the growth of the global active pharmaceutical ingredient market over the forecast period.
By the same token, the healthcare infrastructure has also been revolutionized in the past few decades, which has escalated the healthcare spending enormously. The increased focus on healthcare spending in recent years has also positively influenced the growth of the global active pharmaceutical ingredients market.
Moreover, the emerging trend of shipping or outsourcing R&D activities and manufacturing processes in foraging countries for the purpose of eliminating additional expenses and costs as well as better operational efficiency has also played a positive role in supporting the growth of the global active pharmaceutical ingredients market.
In addition, the rising trend of precision or specialty medicines all across the world is also estimated to give a number of breakthroughs to the growth of the global active pharmaceutical ingredients market in the given timeframe.
Furthermore, the constantly soaring number of chronic ailments among the population and various technological advancements in API manufacturing is also augmenting the growth of the global active pharmaceutical ingredients market.
In the present-day world, the global market is also witnessing huge implementation of artificial intelligence-based drug discovery instruments and techniques which further accelerates the growth of the global active pharmaceutical ingredients market.
However, the intense rivalry between the leading API manufacturers as well as increasing development of anti-counterfeit drugs is likely to restrain the growth of the global active pharmaceutical ingredients market in the coming years.
The global active pharmaceutical ingredients market is segmented on the basis of type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region. On the basis of the type, the active pharmaceutical ingredients market is segmented into Innovative Active Pharmaceutical Ingredients and Generic Active Pharmaceutical Ingredients. On the basis of type of manufacturer active pharmaceutical ingredients market segment is divided into Captive API Manufacturers, Merchant API Manufacturers. Further, On the basis of type of synthesis segment is divided into Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients. On the basis of type of drug segment is bifurcated into Prescription Drugs, Over-The-Counter Drugs. Furthermore, on the basis of therapeutic application active pharmaceutical ingredients market segmented into Communicable Diseases, Oncology, Pain Management, Cardiovascular Diseases, Diabetes, Respiratory Diseases, and Other Therapeutic Applications.
The global active pharmaceutical ingredients market is dominated by Pfizer Inc., Novartis AG, Sanofi, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company., GlaxoSmithKline plc., Merck Sharp & Dohme Corp., AbbVie Inc., AstraZeneca, Aurobindo Pharma, BASF SE, Dr. Reddy’s Laboratories Ltd., LUPIN., Mylan N.V., Sun Pharmaceutical Industries Ltd, Piramal Pharma Solutions, Sandoz International GmbH, Saneca Pharmaceuticals and others.
At present, North America monopolizes the global active pharmaceutical ingredients market and is projected to carry on its citadel for a couple more years. All the more, this region is estimated to elevate its market share in the forthcoming future, due to the growing incidences of disease and increasing geriatric population.
Currently, the largest share of the market in North America is with the United States. On the other hand, most of the API requirements are fulfilled through imports from the Asian Markets.
In addition, according to the US trade statistics, around 75% to 80% of the APIs shipped to the United States are from India and China, as these nations have deep-rooted manufacturing facilities and a plenty of manpower resources providing its services to the pharmaceutical sector.
Furthermore, the latest trade and political policies enforced by the US government to escalate import taxes and duties are further projected to propel operational costs and boost the pricing pressure on the manufacturers.
Noticeably, the FDA has also advanced the application fees for new drug approvals and has also elevated the number of regular inspections conducted on several different off-shore contract manufacturing services to make certain the yield of superior-quality products to the United States market.
The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.
A research report on the Active Pharmaceutical Ingredients market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product designs and launches
Current product compliance
Reimbursement
Concerns for use of Active Pharmaceutical Ingredients
Advantages of Active Pharmaceutical Ingredients
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
To learn more about this report, request a free sample copy
1. Global Active Pharmaceutical Ingredients Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Active Pharmaceutical Ingredients Market Overview
2.1. Introduction
2.1.1. Introduction
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Active Pharmaceutical Ingredients Market Snapshot
2.4. Global Active Pharmaceutical Ingredients Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Active Pharmaceutical Ingredients Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Active Pharmaceutical Ingredients Market, By Type
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Type
3.1.2. BPS Analysis, By Type
3.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Type
3.2.1. Synthetic APIs
3.2.2. Biotech APIs
3.3. Global Active Pharmaceutical Ingredients Market Attractiveness Index, By Type
4. Global Active Pharmaceutical Ingredients Market, By Application
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Application
4.1.2. BPS Analysis, By Application
4.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Application
4.2.1. Oncology
4.2.2. Diabetes
4.2.3. Cardiovascular Disease
4.2.4. CNS and Neurological Disorders
4.2.5. Endocrinology
4.2.6. Other
4.3. Global Active Pharmaceutical Ingredients Market Attractiveness Index, By Application
5. Global Active Pharmaceutical Ingredients Market, By Region
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Region
5.1.2. BPS Analysis, By Region
5.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Region
5.2.1. North America
5.2.2. Latin America
5.2.3. Europe
5.2.4. Asia Pacific
5.2.5. Middle East
5.2.6. Africa
5.3. Global Active Pharmaceutical Ingredients Market Attractiveness Index, By Region
6. North America Active Pharmaceutical Ingredients Market Analysis and Forecast, 2020–2028
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Country
6.1.2. BPS Analysis, By Country
6.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
6.2.1. U.S. Active Pharmaceutical Ingredients Market
6.2.2. Canada Active Pharmaceutical Ingredients Market
6.3. North America Active Pharmaceutical Ingredients Market, By Type
6.3.1. Synthetic APIs
6.3.2. Biotech APIs
6.4. North America Active Pharmaceutical Ingredients Market, By Application
6.4.1. Oncology
6.4.2. Diabetes
6.4.3. Cardiovascular Disease
6.4.4. CNS and Neurological Disorders
6.4.5. Endocrinology
6.4.6. Other
6.5. North America Active Pharmaceutical Ingredients Market Attractiveness Index
6.5.1. By Country
6.5.2. By Type
6.5.3. By Application
7. Latin America Active Pharmaceutical Ingredients Market Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
7.2.1. Brazil Active Pharmaceutical Ingredients Market
7.2.2. Mexico Active Pharmaceutical Ingredients Market
7.2.3. Argentina Active Pharmaceutical Ingredients Market
7.2.4. Rest of Latin America Active Pharmaceutical Ingredients Market
7.3. Latin America Active Pharmaceutical Ingredients Market, By Type
7.3.1. Synthetic APIs
7.3.2. Biotech APIs
7.4. Latin America Active Pharmaceutical Ingredients Market, By Application
7.4.1. Oncology
7.4.2. Diabetes
7.4.3. Cardiovascular Disease
7.4.4. CNS and Neurological Disorders
7.4.5. Endocrinology
7.4.6. Other
7.5. Latin America Active Pharmaceutical Ingredients Market Attractiveness Index
7.5.1. By Country
7.5.2. By Type
7.5.3. By Application
8. Europe Active Pharmaceutical Ingredients Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
8.2.1. U.K. Active Pharmaceutical Ingredients Market
8.2.2. Germany Active Pharmaceutical Ingredients Market
8.2.3. Italy Active Pharmaceutical Ingredients Market
8.2.4. France Active Pharmaceutical Ingredients Market
8.2.5. Spain Active Pharmaceutical Ingredients Market
8.2.6. Russia Active Pharmaceutical Ingredients Market
8.2.7. Poland Active Pharmaceutical Ingredients Market
8.2.8. BENELUX Active Pharmaceutical Ingredients Market
8.2.9. NORDIC Active Pharmaceutical Ingredients Market
8.2.10. Rest of Europe Active Pharmaceutical Ingredients Market
8.3. Europe Active Pharmaceutical Ingredients Market, By Type
8.3.1. Synthetic APIs
8.3.2. Biotech APIs
8.4. Europe Active Pharmaceutical Ingredients Market, By Application
8.4.1. Oncology
8.4.2. Diabetes
8.4.3. Cardiovascular Disease
8.4.4. CNS and Neurological Disorders
8.4.5. Endocrinology
8.4.6. Other
8.5. Europe Active Pharmaceutical Ingredients Market Attractiveness Index
8.5.1. By Country
8.5.2. By Type
8.5.3. By Application
9. Asia Pacific Active Pharmaceutical Ingredients Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
9.2.1. China Active Pharmaceutical Ingredients Market
9.2.2. India Active Pharmaceutical Ingredients Market
9.2.3. Japan Active Pharmaceutical Ingredients Market
9.2.4. Australia And New Zealand Active Pharmaceutical Ingredients Market
9.2.5. South Korea Active Pharmaceutical Ingredients Market
9.2.6. ASEAN Active Pharmaceutical Ingredients Market
9.2.7. Rest of Asia Pacific Active Pharmaceutical Ingredients Market
9.3. Asia Pacific Active Pharmaceutical Ingredients Market, By Type
9.3.1. Synthetic APIs
9.3.2. Biotech APIs
9.4. Asia Pacific Active Pharmaceutical Ingredients Market, By Application
9.4.1. Oncology
9.4.2. Diabetes
9.4.3. Cardiovascular Disease
9.4.4. CNS and Neurological Disorders
9.4.5. Endocrinology
9.4.6. Other
9.5. Asia Pacific Active Pharmaceutical Ingredients Market Attractiveness Index
9.5.1. By Country
9.5.2. By Type
9.5.3. By Application
10. Middle East Active Pharmaceutical Ingredients Market, By Region
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
10.2.1. GCC Countries Active Pharmaceutical Ingredients Market
10.2.2. Israel Active Pharmaceutical Ingredients Market
10.2.3. Oman Active Pharmaceutical Ingredients Market
10.2.4. Rest of Middle East Active Pharmaceutical Ingredients Market
10.3. Middle East Active Pharmaceutical Ingredients Market, By Type
10.3.1. Synthetic APIs
10.3.2. Biotech APIs
10.4. Middle East Active Pharmaceutical Ingredients Market, By Application
10.4.1. Oncology
10.4.2. Diabetes
10.4.3. Cardiovascular Disease
10.4.4. CNS and Neurological Disorders
10.4.5. Endocrinology
10.4.6. Other
10.5. Middle East Active Pharmaceutical Ingredients Market Attractiveness Index
10.5.1. By Country
10.5.2. By Type
10.5.3. By Application
11. Africa Active Pharmaceutical Ingredients Market, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
11.2.1. South Africa Active Pharmaceutical Ingredients Market
11.2.2. Egypt Active Pharmaceutical Ingredients Market
11.2.3. North Africa Active Pharmaceutical Ingredients Market
11.2.4. Rest of Africa Active Pharmaceutical Ingredients Market
11.3. Africa Active Pharmaceutical Ingredients Market, By Type
11.3.1. Synthetic APIs
11.3.2. Biotech APIs
11.4. Africa Active Pharmaceutical Ingredients Market, By Application
11.4.1. Oncology
11.4.2. Diabetes
11.4.3. Cardiovascular Disease
11.4.4. CNS and Neurological Disorders
11.4.5. Endocrinology
11.4.6. Other
11.5. Africa Active Pharmaceutical Ingredients Market Attractiveness Index
11.5.1. By Country
11.5.2. By Type
11.5.3. By Application
12. Recommendation
12.1. Market Strategy
13. Competitive Landscape
13.1. Competition Dashboard
13.2. List and Company Overview of Global Key Players
13.3. Company Profiles
13.3.1. Pfizer
13.3.1.1. Company Overview
13.3.1.2. Financial Overview
13.3.1.3. Product Portfolio
13.3.1.4. Key Developments
13.3.1.5. Business Strategies
13.3.2. Novartis International
13.3.3. Sanofi
13.3.4. Boehringer Ingelheim
13.3.5. Bristol-Myers Squibb
13.3.6. Teva Pharmaceutical
13.3.7. Eli Lilly and Company
13.3.8. GlaxoSmithKline
13.3.9. Merck & Co
13.3.10. AbbVie
13.3.11. Johnson & Johnson
13.3.12. Bayer
13.3.13. Sun Pharmaceutical Industries
13.3.14. DSM
13.3.15. Hisun Pharmacy
13.3.16. Huahai Pharmaceutical
13.3.17. North China Pharmaceutical Group
13.3.18. Shandong Lukang Pharmaceutical
13.3.19. Haerbin Pharmaceutical Group
13.3.20. Shandong Xinhua Pharmaceutical
13.3.21. Jiangsu Hengrui Medicine
13.3.22. Lonza Group
13.3.23. Aurobindo Pharma
13.3.24. Lupin
13.3.25. Biocon
14. Acronyms
The global active pharmaceutical ingredients market is estimated to reach at a value of US$ 184.7 Bn by the end of 2020 and expected to reach at a value of US$ 309.8 Bn by 2028 with a significant CAGR of 6.7%.
The constantly increasing number of research and development activities associated with drugs and medicines across the world and the number of healthcare activities as well as usage of drugs, medicines and biologics in treating patients, worldwide are the key factors driving the growth of market
The global active pharmaceutical ingredients market is segmented on the basis of type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region.
Pfizer Inc., Novartis AG, Sanofi, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company., GlaxoSmithKline plc., Merck Sharp & Dohme Corp., AbbVie Inc., AstraZeneca, Aurobindo Pharma, BASF SE, Dr. Reddy’s Laboratories Ltd., LUPIN., Mylan N.V., Sun Pharmaceutical Industries Ltd, Piramal Pharma Solutions, Sandoz International GmbH, Saneca Pharmaceuticals and others are the key participating players in the market